• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Adjunctive D-Cycloserine for transcranial magnetic stimulation can improve treatment-resistant depressive symptoms

byKeerthana Pasumarthi
October 21, 2022
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

Click here to read this study in JAMA Psychiatry.

RELATED REPORTS

A novel therapy targeting γ-aminobutyric acid is safe and may be effective in major depressive disorder

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

2 Minute Medicine Rewind May 4, 2026

Tags: #major depressive disorderbrain stimulationpsychiatry
Previous Post

Ruxolitinib results in improved repigmentation as compared to vehicle-control in nonsegmental vitiligo

Next Post

#VisualAbstract: Bronchodilators do not improve symptomatic tobacco-exposure in patients with preserved lung function

RelatedReports

Parents often unaware of adolescents’ suicidal thoughts
Chronic Disease

A novel therapy targeting γ-aminobutyric acid is safe and may be effective in major depressive disorder

May 27, 2026
Children’s hospital visits for suicide ideation and attempts are increasing
Chronic Disease

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

May 13, 2026
Systematic review examines benefits and adverse effects of cannabinoid therapy
Weekly Rewinds

2 Minute Medicine Rewind May 4, 2026

May 4, 2026
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse
Chronic Disease

Transcranial magnetic stimulation may reduce combat-related post-traumatic stress disorder symptoms

April 17, 2026
Next Post
#VisualAbstract: Bronchodilators do not improve symptomatic tobacco-exposure in patients with preserved lung function

#VisualAbstract: Bronchodilators do not improve symptomatic tobacco-exposure in patients with preserved lung function

Post-intensive care syndrome risk in out-of-hospital cardiac arrest patients

Risk factors and rates of post-intensive care syndrome for patients with out-of-hospital cardiac arrest

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • TikTok’s cortisol face trend meets endocrine reality
  • Semaglutide (Ozempic) raises questions about mood and nonresponse
  • Cruise ship hantavirus outbreak turns into a global contact tracing test
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.